BUDOCOL-TABLET
MRP: 3,900
Packaging: 10X10
Pack Type: tablet
Composition:
Budesonide Controlled Release Tablets 9mg
Indication:
Used in the treatment of asthma and Ulcerative colitis
Description:
Budesonide Controlled Release Tablets 9mg are a corticosteroid formulation designed for targeted, controlled release in the gastrointestinal tract. This medication is primarily used in the management of mild to moderate Crohn’s disease affecting the ileum and/or ascending colon. Budesonide has local anti-inflammatory effects and undergoes significant first-pass metabolism, reducing systemic side effects compared to conventional steroids. The controlled-release technology ensures that the drug is delivered where it is needed most, providing effective symptom relief with minimal systemic exposure.
Tags:
- Targeted delivery to the intestine for local anti-inflammatory action
- Reduces symptoms of Crohn’s disease with fewer systemic effects
- Controlled-release formula improves therapeutic efficacy
- Lower risk of steroid-related side effects
- High safety profile due to minimal systemic absorption
Usage Information
Dosage
Usual Adult Dose: 9 mg once daily in the morning, or as prescribed by a physician Swallow whole with water—do not crush or chew Duration of therapy depends on clinical response, usually 8 weeks or as directed
Side Effects
Headache Nausea Fatigue Acne Abdominal pain Flatulence Risk of adrenal suppression with long-term use Mood changes (rare)
Contraindications
Known hypersensitivity to budesonide or formulation components Active systemic fungal infections Use with caution in patients with liver impairment Avoid abrupt discontinuation after prolonged use Not recommended during pregnancy unless clearly needed
Availability
Budesonide 9mg tablets, controlled release budesonide, Crohn's disease treatment, GI anti-inflammatory, corticosteroid tablets, steroid for intestinal inflammation, budesonide for IBD